More heart failure patients will be taking an aldosterone antagonist
More heart failure patients will be taking an aldosterone antagonist...spironolactone or the new Inspra (eplerenone).
These drugs have been shown to improve survival...but in different types of patients.
Spironolactone improves survival in patients with Class III or IV heart failure and reduced left ventricular function.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote